Norway Health Clinical Trials Norway Health RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: lorlatinib;   Drug: crizotinib;   Drug: brigatinib;   Drug: ceritinib;   Drug: alectinib;   Drug: atezolizumab;   Drug: bevacizumab;   Drug: paclitaxel;   Drug: carboplatin;   Drug: docetaxel;   Drug: erlotinib;   Drug: gefitinib;   Drug: afatinib;   Drug: dacomi tinib;   Drug: osimertinib;   Drug: pembrolizumab;   Drug: nivolumab;   Drug: entrectinib Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials

POINT - Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain
Conditions:   Chronic Pain;   Opioid Use Intervention:   Behavioral: POINT1 Sponsors:   Helse Stavanger HF;   The Research Council of Norway Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2023 Category: Research Source Type: clinical trials